Abstract
The generation of leukotrienes C4, D4 and E4 from arachidonic acid is dependent upon the activity of 5-lipoxygenase (5-LOX). The effects of RG 6866 (N-methyl-4-benzyloxyphenylacetohydroxamic acid) on the activity of guinea pig 5-LOXin vitro andin vivo were determined in the present study. The generation of 5-hydroxy-6,8,11,14-eicosatetraenoic acid (5-HETE) from arachidonic acid by isolated guinea pig peritoneal polymorphonuclear (PMN) cells was inhibited by incubation with RG 6866 (IC50=0.20 μM). A similar effect (IC50=0.23 μM) was observed when 5-HETE production was measured in a supernatant fraction from PMNs. Additionally, the compound did not inhibit3H-LTD4 binding to guinea pig membranes. In actively sensitized guinea pigs pretreated with indomethacin, propranolol and pyrilamine, RG 6866 inhibited antigen-induced systemic anaphylaxis and LTD4-dependent bronchoconstriction in a dose-dependent manner following oral administration. In the pulmonary anaphylaxis model, significant (p<0.05) inhibition of the mortality was observed within 30 min and maintained through four hours after treatment with RG 6866 (50 mg/kg i.g.). Finally, orally administered RG 6866 inhibited the formation of LTC4 in these animals with an ED50=24.0 mg/kg. These findings indicate that RG 6866 is an inhibitor of 5-LOX bothin vitro andin vivo.
Similar content being viewed by others
References
P. M. Simmons, J. A. Salmon and S. Moncada,The release of leukotriene B 4 during experimental inflammation. Biochem. Pharma.32, 1353–1359 (1983).
M. J. H. Smith, A. W. Ford-Hutchinson and M. A. Bray,Leukotriene B: A potential mediator of inflammation. J. Pharm. Pharmac.32, 517–518 (1980).
J. H. Fleisch, L. E. Rinkema, K. D. Haisch, D. Swanson-Bean, T. Goodson, P. P. K. Ho and W. S. Marshall,LY-171883, 1-[2-hydroxy-3-propyl-4-4-(1H)-tetrazol-5-yl) butoxy] phenyl-ethanone, an orally active leukotriene D 4 antagonist. J. Pharmac. Exp. Ther.233, 148–157 (1985).
G. W. Carnathan, J. H. Sanner, J. M. Thompson, C. M. Prusa and M. Miyano,Antagonism of the in vivo and in vitro effects of leukotriene D 4 by SC-39070 in guinea pigs. Agents and Actions20, 124–132 (1987).
D. W. P. Hay, R. M. Muccitelli, S. S. Tucker, L. M. Vickery-Clark, K. A. Wilson, J. G. Gleason, R. F. Hall, M. A. Wasserman and T. J. Torphy,Pharmacologic profile of SK&F 104353: A novel, potent and selective peptidoleukotriene receptor antagonist in guinea pig and human airways. J. Pharmacol. Exp. Ther.243, 474–481 (1987).
D. W. Snyder, R. E. Giles, R. A. Keith, Y. K. Yee and R. D. Krell,in vitro pharmacology of ICI-198615: A novel, potent and selective peptide leukotriene antagonist. J. Pharmac. Exp. Ther.243, 548–556 (1987).
D. E. Griswold, P. J. Marshall, E. F. Webb, R. Godfrey, J. Newton Jr., M. J. DiMartino, H. M. Sarau, J. G. Gleason, G. Poste and N. Hanna,SK&F 86002: A structurally novel anti-inflammatory agent that inhibits lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid. Biochem. Pharmac.36, 3463–3470 (1987).
C. S. McFarlane, R. Hamel and A. W. Ford-Hutchinson,Effects of a 5-lipoxygenase inhibitor (L-651,392)on primary and late pulmonary responses to ascaris antigen in the squirrel monkey. Agents and Actions22, 63–68 (1987).
S. M. Coutts, A. Khandwala, R. Van Inwegen, U. Chakraborty, J. Musser, J. Bruens, N. Jariwala, V. Dally-Meade, R. Ingram, T. Pruss, H. Jones, E. Neiss and I. Weinryb,Arylmethyl phenyl ethers: A new class of specific inhibitor of 5-lipoxygenase. InProstaglandins, Leukotrienes and Lipoxins. (Ed. J. M. Bailey) pp. 627–637, Plenum Publishing Corp., New York 1985.
R. G. Van Inwegen, A. Khandwala, R. Gordon, P. Sonnino, S. Coutts and S. Jolly,REV-5901: An orally effective peptidoleukotriene antagonist, detailed biochemical/pharmacological profile. J. Pharma. Exp. Ther.241, 117–124 (1987).
D. Sweeney, J. Travis, R. Gordon, S. Coutts, N. Jariwala, F. Huang and G. Carnathan,The effect of a novel inhibitor of 5-lipoxygenase on pulmonary anaphylaxis in sensitized guinea pigs. Fed. Proc.46, 1302 (1987).
R. G. Van Inwegen, G. W. Nuss and G. W. Carnathan,Antagonism of peptidoleukotrienes and inhibition of systemic anaphylaxis by RG-12525 in guinea pigs. Life Sciences44, 799–807 (1989).
B. M. Weichman, R. M. Muccitelli, R. R. Osborn, D. A. Holden, J. G. Gleason and M. A. Wasserman,In vitro and in vivo mechanisms of leukotriene-mediated bronchoconstriction in the guinea pig. J. Pharma. Exp. Ther.222, 202–208 (1982).
C. J. Hanna, M. K. Bach, P. D. Pare and R. R. Schellenberg,Slow-reacting substances (leukotrienes) contract human airway and pulmonary vascular smooth muscle in vitro. Nature (London)290, 343–344 (1981).
J. Chang, M. D. Skowronek, M. L. Cherney and A. J. Lewis,Differential effects of putative lipoxygenase inhibitors on arachidonic acid metabolism in cell-free and intact cell preparations. Inflammation8, 143–155 (1984).
T. Yoshimoto, C. Yokoyama, K. Ochi, S. Yamamoto, Y. Maki, Y. Ashida, S. Terao and M. Shiraishi,2,3,5-Trimethyl-6-(12-hydroxy-5, 10-dodecadiynyl)-1,4-benzoquinone (AA-861), A selective inhibitor of the 5-lipoxygenase reaction and the biosynthesis of slow-reacting substance of anaphylaxis. Biochemica Et Biophysica Acta713, 470–473 (1982).
P. Andersson and H. Bergstrand,Antigen-induced bronchial anaphylaxis in actively sensitized guinea-pig: Effects of longterm treatment with sodium cromoglycate and aminophylline. Br. J. Pharmac.74, 601–609 (1981).
J. M. Hand, S. F. Schwalm and A. J. Lewis,Antagonism of antigen-induced contraction of isolated guinea-pig trachea by 5-lipoxygenase inhibitors. Int. Archs. Allergy Appl. Immun.79, 8–13 (1986).
R. O. Salonen,Actions of bronchodilator drugs, glucocorticoid and their combinations on airways in rats and guinea pigs. Acta Pharma. Toxicol.57, Suppl. III, 1–38 (1985).
N. C. Turner and C. T. Dollery,Release of arachidonic acid metabolites and histamine from sensitized guinea-pig lung following antigen challenge. Br. J. Pharmac.93, 751–758 (1988).
Author information
Authors and Affiliations
Additional information
Previously designated as REV-6866 in a preliminary communication.
Rights and permissions
About this article
Cite this article
Carnathan, G.W., Sweeney, D.M., Travis, J.J. et al. The inhibition of 5-lipoxygenase by RG 6866. Agents and Actions 28, 204–211 (1989). https://doi.org/10.1007/BF01967402
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01967402